my account
Login
  Loading... Please wait...

Product Details

Bromocriptine mesylate | Dopamine D2/D3 agonist

Bromcriptine mesylate (22260-51-1) is a dopamine D2 receptor agonist. Inhibits prolactin production3. Decreases cocaine self-administration in the rat4. Active in vivo.

References/Citations
1) Nilsson and Hokfelt (1978), Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise, and during insulin induced hypoglycemia; Acta Endocrinol., Supp. 216 83
2) Seeman and Van Tol (1994), Dopamine receptor pharmacology; Trends Pharmacol. Sci., 15 264
3) Carvalho et al. (2015), Maternal prolactin inhibition causes changes in leptin at 22- and 30-day old pups; Horm. Metab. Res., 47 528
4) Hubner and Koob (1990), Bromocriptine produces decreases in cocaine self-administration in the rat; Neuropsychopharmacol., 3 101

swipe
Bromocriptine mesylate | 22260-51-1 | Structure | Supplier

Catalog#  10-1096

$65.00
Quantity
Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee.
 
Request Bulk Quote
CAS:
22260-51-1
Catalog Number:
10-1096
Activity:
Dopamine D2/D3 agonist
Chemical Name:
(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-ergotaman-3',6',18-trione methanesulfonate
Molecular Weight:
750.72
Molecular Formula:
C32H40BrN5O5 CH3SO3H
Solubility:
Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 6 mg/ml).
Physical Properties:
White solid
Purity:
>98% by TLC
NMR (Conforms)
Storage Temperature:
RT
Stability:
Stable for 2 years as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months
Shipping Code:
RT
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.

Share Focus

Connect with Focus

Click the button below to add the Bromocriptine mesylate | Dopamine D2/D3 agonist to your wish list.